Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors.
about
A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity.Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.Molecular basis for binding and subtype selectivity of 1,4-benzodiazepine antagonist ligands of the cholecystokinin receptor.Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modelingSensitivity of cholecystokinin receptors to membrane cholesterol content.Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol.Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.Structural basis of cholecystokinin receptor binding and regulation.Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.Environmentally sensitive fluorescent sensors based on synthetic peptides.
P2860
Q34073933-3B340B60-A6C7-42CC-AE66-1B5EF015BAE9Q35533535-C4CE8C34-A159-46DD-ACB0-CDFB539C38E5Q35625928-254F5DA0-E5DE-4D4A-B2B3-11838236D6C4Q36002904-B1417169-16F7-4D67-B26F-95B4CB91471AQ36237729-48CEFD1F-8F2D-4228-A571-E78A1B1E0C64Q36329391-E20E411C-FCC5-468E-8352-DCB2D119791FQ36654207-11D958E9-E291-4EAE-8F43-B239EA574CC8Q36683781-8D8191F8-218C-4A26-A54B-28A4444813A6Q36829195-0774C9CC-73F7-4EAD-BFE5-2DBCC06D72CEQ36944147-BB32999F-D098-48E8-8D94-3534F5E92F34Q37084882-26336253-77B7-4104-B028-AE736B4F9BC5Q37982692-249F219A-40E4-4EE6-A86F-8B0139E47936
P2860
Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@en
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@nl
type
label
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@en
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@nl
prefLabel
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@en
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@nl
P2093
P2860
P356
P1476
Fluorescent indicators distrib ...... d B cholecystokinin receptors.
@en
P2093
Delia I Pinon
Kaleeckal G Harikumar
Laurence J Miller
P2860
P304
27072-27080
P356
10.1074/JBC.M605098200
P407
P577
2006-07-20T00:00:00Z